NASDAQ:SMTI Sanara MedTech - SMTI Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sanara MedTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $39.96 +0.21 (+0.53%) (As of 03/21/2023 12:00 AM ET) Add Compare Share Share Today's Range$39.00▼$40.7350-Day Range$39.75▼$48.7452-Week Range$17.41▼$49.50Volume29,971 shsAverage Volume12,379 shsMarket Capitalization$331.67 millionP/E RatioN/ADividend YieldN/APrice Target$50.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Sanara MedTech MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside25.1% Upside$50.00 Price TargetShort InterestBearish2.74% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.55Based on 7 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.27) to $0.28 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.86 out of 5 starsMedical Sector716th out of 983 stocksSurgical Appliances & Supplies Industry17th out of 23 stocks 3.5 Analyst's Opinion Consensus RatingSanara MedTech has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $50.00, Sanara MedTech has a forecasted upside of 25.1% from its current price of $39.96.Amount of Analyst CoverageSanara MedTech has received no research coverage in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted2.74% of the float of Sanara MedTech has been sold short.Short Interest Ratio / Days to CoverSanara MedTech has a short interest ratio ("days to cover") of 8.6.Change versus previous monthShort interest in Sanara MedTech has recently increased by 3.77%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldSanara MedTech does not currently pay a dividend.Dividend GrowthSanara MedTech does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SMTI. Previous Next 1.4 News and Social Media Coverage News SentimentSanara MedTech has a news sentiment score of -0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.34 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Sanara MedTech this week, compared to 0 articles on an average week.Search Interest3 people have searched for SMTI on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sanara MedTech insiders have not sold or bought any company stock.Percentage Held by Insiders58.40% of the stock of Sanara MedTech is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 4.03% of the stock of Sanara MedTech is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Sanara MedTech are expected to grow in the coming year, from ($1.27) to $0.28 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Sanara MedTech is -26.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sanara MedTech is -26.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSanara MedTech has a P/B Ratio of 10.12. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Sanara MedTech (NASDAQ:SMTI) StockSanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.Read More Receive SMTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sanara MedTech and its competitors with MarketBeat's FREE daily newsletter. Email Address SMTI Stock News HeadlinesMarch 21, 2023 | americanbankingnews.comSanara MedTech (NASDAQ:SMTI) Releases Quarterly Earnings Results, Misses Expectations By $0.04 EPSMarch 21, 2023 | americanbankingnews.comSanara MedTech (NASDAQ:SMTI) Announces Earnings Results, Misses Estimates By $0.04 EPSMarch 21, 2023 | Investing Daily (Ad)27 U.S. Cities Where Stocks Yield 26% a YearWhat’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate. March 20, 2023 | finance.yahoo.comSanara MedTech Inc. Announces Fourth Quarter and Full Year 2022 ResultsMarch 20, 2023 | americanbankingnews.comAnalyzing Sanara MedTech (NASDAQ:SMTI) & STERIS (NYSE:STE)March 17, 2023 | benzinga.comEarnings Outlook For Sanara MedTechMarch 6, 2023 | finance.yahoo.comSanara MedTech Inc. Announces Fourth Quarter and Full Year 2022 Earnings Release and Conference Call DatesFebruary 22, 2023 | msn.comSanara MedTech expects 119% growth in Q4 toplineMarch 21, 2023 | Investing Daily (Ad)27 U.S. Cities Where Stocks Yield 26% a YearWhat’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate. February 22, 2023 | finance.yahoo.comSanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2022February 14, 2023 | finance.yahoo.comSanara MedTech Inc. (NASDAQ:SMTI) On The Verge Of Breaking EvenJanuary 18, 2023 | finance.yahoo.comSanara MedTech Inc.'s (NASDAQ:SMTI) largest shareholders are individual investors with 34% ownership, insiders own 32%December 8, 2022 | seekingalpha.comSanara MedTech: Triple-Digit Revenue Upside In Q3, Expanding Footprint, Reaffirm BuyNovember 21, 2022 | finance.yahoo.comSanara MedTech to Participate in Two Upcoming Healthcare ConferencesNovember 15, 2022 | seekingalpha.comSanara Medtech, Inc. (SMTI) Q3 2022 Earnings Call TranscriptNovember 15, 2022 | finance.yahoo.comSanara MedTech Inc. Announces Third Quarter 2022 ResultsNovember 3, 2022 | finance.yahoo.comSanara MedTech and InfuSystem Announce Wound Therapy PartnershipNovember 1, 2022 | finance.yahoo.comSanara MedTech Inc. Announces Third Quarter 2022 Earnings Release and Conference Call DatesOctober 18, 2022 | nz.finance.yahoo.comSanara MedTech's (NASDAQ:SMTI) investors will be pleased with their enviable 353% return over the last five yearsAugust 19, 2022 | nasdaq.comUS$50.00 - That's What Analysts Think Sanara MedTech Inc. (NASDAQ:SMTI) Is Worth After These ResultsAugust 17, 2022 | finance.yahoo.comSanara MedTech Inc. (NASDAQ:SMTI) Just Reported And Analysts Have Been Lifting Their Price TargetsAugust 16, 2022 | seekingalpha.comSanara MedTech Inc. (SMTI) CEO Zachary Fleming on Q2 2022 Results - Earnings Call TranscriptAugust 15, 2022 | uk.finance.yahoo.comSanara MedTech Inc. (SMTI)August 15, 2022 | finance.yahoo.comSanara MedTech Inc. Announces Second Quarter 2022 ResultsAugust 11, 2022 | finance.yahoo.comWhat Type Of Shareholders Own The Most Number of Sanara MedTech Inc. (NASDAQ:SMTI) Shares?August 3, 2022 | finance.yahoo.comSanara MedTech Inc. Announces Second Quarter 2022 Earnings Release and Conference Call DatesJune 12, 2022 | finance.yahoo.comWe're Hopeful That Sanara MedTech (NASDAQ:SMTI) Will Use Its Cash WiselySee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SMTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sanara MedTech and its competitors with MarketBeat's FREE daily newsletter. Email Address SMTI Company Calendar Last Earnings3/20/2023Today3/21/2023Next Earnings (Estimated)5/15/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SMTI CUSIPN/A CIK714256 Webwww.wndm.com Phone(817) 529-2300FaxN/AEmployees40Year FoundedN/APrice Target and Rating Average Stock Price Forecast$50.00 High Stock Price Forecast$50.00 Low Stock Price Forecast$50.00 Forecasted Upside/Downside+24.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.49) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,920,000.00 Net Margins-30.33% Pretax Margin-35.15% Return on Equity-32.84% Return on Assets-25.56% Debt Debt-to-Equity RatioN/A Current Ratio2.23 Quick Ratio1.83 Sales & Book Value Annual Sales$24.14 million Price / Sales13.79 Cash FlowN/A Price / Cash FlowN/A Book Value$3.95 per share Price / Book10.15Miscellaneous Outstanding Shares8,300,000Free Float3,454,000Market Cap$332.83 million OptionableNot Optionable Beta1.88 Key ExecutivesZach FlemingChief Executive OfficerMichael D. McNeilSecretary, Chief Financial & Accounting OfficerRebecca E. McmahonPresident-Research & DevelopmentSusan DieterClinical Director, Head-Wound Care & SurgicalBill FitzgeraldCompliance OfficerKey CompetitorsVicarious SurgicalNYSE:RBOTInogenNASDAQ:INGNCollPlant BiotechnologiesNASDAQ:CLGNAvanos MedicalNYSE:AVNSUtah Medical ProductsNASDAQ:UTMDView All CompetitorsInsiders & InstitutionsBamco Inc. NYBought 9,841 shares on 2/15/2023Ownership: 0.129%Millennium Management LLCBought 8,004 shares on 2/15/2023Ownership: 0.096%Morgan StanleyBought 1,900 shares on 2/15/2023Ownership: 0.062%Price T Rowe Associates Inc. MDBought 5,900 shares on 2/14/2023Ownership: 0.071%683 Capital Management LLCBought 4,966 shares on 2/14/2023Ownership: 0.060%View All Insider TransactionsView All Institutional Transactions SMTI Stock - Frequently Asked Questions Should I buy or sell Sanara MedTech stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sanara MedTech in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SMTI shares. View SMTI analyst ratings or view top-rated stocks. What is Sanara MedTech's stock price forecast for 2023? 1 Wall Street research analysts have issued twelve-month price targets for Sanara MedTech's shares. Their SMTI share price forecasts range from $50.00 to $50.00. On average, they expect the company's share price to reach $50.00 in the next twelve months. This suggests a possible upside of 24.7% from the stock's current price. View analysts price targets for SMTI or view top-rated stocks among Wall Street analysts. How have SMTI shares performed in 2023? Sanara MedTech's stock was trading at $45.50 on January 1st, 2023. Since then, SMTI shares have decreased by 11.9% and is now trading at $40.10. View the best growth stocks for 2023 here. When is Sanara MedTech's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 15th 2023. View our SMTI earnings forecast. How were Sanara MedTech's earnings last quarter? Sanara MedTech Inc. (NASDAQ:SMTI) posted its quarterly earnings results on Monday, March, 20th. The company reported ($0.26) earnings per share for the quarter, missing analysts' consensus estimates of ($0.22) by $0.04. The firm had revenue of $15.32 million for the quarter. Sanara MedTech had a negative net margin of 30.33% and a negative trailing twelve-month return on equity of 32.84%. During the same period last year, the firm posted ($0.48) earnings per share. What guidance has Sanara MedTech issued on next quarter's earnings? Sanara MedTech updated its fourth quarter 2022 earnings guidance on Wednesday, February, 22nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $15.30 million-$15.30 million, compared to the consensus revenue estimate of $14.80 million. What other stocks do shareholders of Sanara MedTech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sanara MedTech investors own include Lakeland Industries (LAKE), Ovintiv (OVV), SIG (SHI), Zynerba Pharmaceuticals (ZYNE), AbbVie (ABBV), American Airlines Group (AAL), Abbott Laboratories (ABT), Aurora Cannabis (ACB), AC Immune (ACIU) and Applied Genetic Technologies (AGTC). What is Sanara MedTech's stock symbol? Sanara MedTech trades on the NASDAQ under the ticker symbol "SMTI." Who are Sanara MedTech's major shareholders? Sanara MedTech's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Geode Capital Management LLC (0.34%), Susquehanna International Group LLP (0.18%), Bamco Inc. NY (0.13%), Citigroup Inc. (0.11%), Millennium Management LLC (0.10%) and Price T Rowe Associates Inc. MD (0.07%). Insiders that own company stock include Shawn M Bowman and Zachary B Fleming. View institutional ownership trends. How do I buy shares of Sanara MedTech? Shares of SMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Sanara MedTech's stock price today? One share of SMTI stock can currently be purchased for approximately $40.10. How much money does Sanara MedTech make? Sanara MedTech (NASDAQ:SMTI) has a market capitalization of $332.83 million and generates $24.14 million in revenue each year. The company earns $-7,920,000.00 in net income (profit) each year or ($1.49) on an earnings per share basis. How can I contact Sanara MedTech? Sanara MedTech's mailing address is 1200 Summit Avenue Suite 414, Fort Worth TX, 76102. The official website for the company is www.wndm.com. The company can be reached via phone at (817) 529-2300 or via email at ir@sanaramedtech.com. This page (NASDAQ:SMTI) was last updated on 3/21/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.